Patents Assigned to Antelman Technologies, Ltd.
  • Patent number: 5676977
    Abstract: The diamagnetic semiconducting molecular crystal tetrasilver tetroxide (Ag.sub.4 O.sub.4) is utilized for destroying the AIDS virus, destroying AIDS synergistic pathogens and immunity suppressing moieties (ISM) in humans.A single intravenous injection of the devices is all that is required for efficacy at levels of about 40 PPM of human blood. The device molecular crystal contains two mono and two trivalent silver ions capable of "firing" electrons capable of electrocuting the AIDS virus, pathogens and ISM. When administered into the bloodstream, the device electrons will be triggered by pathogens, a proliferating virus and ISM, and when fired will simultaneously trigger a redox chelation mechanism resulting in divalent silver moieties which chelate and bind active sites of the entities destroying them. The devices are completely non-toxic. However, they put stress on the liver causing hepatomegaly, but there is no loss of liver function.
    Type: Grant
    Filed: May 31, 1996
    Date of Patent: October 14, 1997
    Assignee: Antelman Technologies Ltd.
    Inventor: Marvin S. Antelman
  • Patent number: 5575900
    Abstract: Opportunistic decorative mass production gold plating solutions are described which are capable of plating gold at concentrations as low as one-half pennyweight per gallon based on an alkaline gold cyanide complex. The low concentration enables ecological operations as well as low working capital inventory operations. The solutions feature high efficiency "put through" replenishment of gold, and non 24 Karat gold deposition capabilities such as 18 and 14 Karats without the necessity of adding metal salts. The solutions operate over a pH range of one to seven without affecting the stability of the gold cyanide complex in the pH range of 1-2.5. A preferred embodiment of the invention comprises an electrolyte mixture of three buffer salts and two chelating agents capable of depositing bright hard 18 Karat gold colored deposits.
    Type: Grant
    Filed: July 3, 1995
    Date of Patent: November 19, 1996
    Assignees: Antelman Technologies Ltd., Tivian Industries, Ltd.
    Inventors: Marvin S. Antelman, Perry W. Antelman
  • Patent number: 5571520
    Abstract: The employment of molecular crystals as bactericidal, viricidal and algicidal devices, and specifically the molecular semiconductor crystal tetrasilver tetroxide Ag.sub.4 O.sub.4 which has two trivalent and two monovalent silver atoms per molecule, and which through this structural configuration generates electronic activity on a molecular scale capable of killing algae and bacteria via the same mechanism as macroscale electron generators.
    Type: Grant
    Filed: August 4, 1994
    Date of Patent: November 5, 1996
    Assignee: Antelman Technologies Ltd.
    Inventor: Marvin S. Antelman
  • Patent number: 5336499
    Abstract: A novel molecular scale device is described which is bactericidal, fungicidal, viricidal and algicidal. The anti-pathogenic properties of the device are attributed to electron activity indigenous to diamagnetic semiconducting crystals of tetrasilver tetroxide (Ag.sub.4 O.sub.4) which contains two monovalent and two trivalent silver ions in each molecular crystal. When the crystals are activated with an oxidizing agent, they release electrons equivalent to 6.4.times.10.sup.-19 watts per molecule which in effect electrocute pathogens. A multitude of these devices are effective at such low concentrations as 0.3 PPM used as preservatives in a variety of formulations ranging from cosmetics to pharmaceuticals. Indeed, they are intended as active ingredients for pharmaceuticals formulated to destroy such pathogens as Staphylococcus aureus, and epidermidis, the latter of which it completely destroys in a nutrient broth culture of about 1 million organisms at 0.
    Type: Grant
    Filed: November 5, 1992
    Date of Patent: August 9, 1994
    Assignee: Antelman Technologies, Ltd.
    Inventor: Marvin S. Antelman